The problem

Low back pain affects up to 85% of the people, ranking first in terms of years lived with disability.

150 billion € spent every year

150 million sick leave days lost

36,4% rise expected by 2050

The solution

Our solution can be injected into the patients’ spine either at early or late stages of degeneration, allowing for a full regenerative and long-term effect.

Learn More

The benefits

Efficient, safe, and sustainable technology for better healthcare solutions

Learn More

Full regenerative and long-term effect with a single injection

No need for risky surgeries and reoperations

Shortens intervention
time by 90%

Reduces hospitalization
stays by 70%

Promotes circular economy by using animal waste

Leads to significant
healthcare savings

Restores patients’ long active lives

Driving success

With years of expertise, prestigious awards, groundbreaking research, and key partnerships, we’ve built a catalyst for progress in the biotech space. The funding attracted has been cornerstone in positioning us to revolutionize healthcare.

10+

Years of study

Articles Published

~1M

Capital Raised

Funded by

Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Innovation Councial. Neither the European Union nor the granting authority can be held responsible for them.

The opinion of experts

“This new treatment could potentially alter […] ageing, both in the terms of prevention […] but also reversing the biological condition, […] getting a spine that would be more functional with a minimally invasive procedure”

Nuno Neves (Orthopaedic Spine Surgeon) - Advisory Board Member

"We really need to find new solutions to an old problem [...] a more functional way of treating the disease"

Paulo Pereira (Neurosurgeon) - Advisory Board Member

"These animals [...] have a lot of pain and this will be [...] a new opportunity for them"

Irina Amorim (Doctor in Veterinary Medicine) - Member of Advisory Board

"[Current treatments] will ease the symptoms, but won't resolve the situation [...] an alternative treatment is more than welcome"

Flávia Rocha (Doctor in Veterinary Medicine)

On the spotlight

Discover our news

Fetalix participates in AnimalHealth@i3S

Advancing healthcare increasingly relies on collaboration across disciplines and species. The One Health approach recognizes that many biological processes and diseases are shared between humans and animals, creating opportunities for scientific discoveries to generate benefits in both human and veterinary medicine. Events that bring together researchers from these fields play an important role in fostering interdisciplinary collaboration and accelerating innovation.

Fetalix reaches 2000 followers on LinkedIn

Building innovative healthcare solutions extends beyond scientific and technological progress. Engaging with a growing community of researchers, clinicians, partners, and supporters is an important part of advancing new ideas and fostering collaboration in regenerative medicine.

Fetalix survey highlights strong interest in regenerative therapies for dogs

Understanding the needs and expectations of end users is an essential step in the development of new healthcare technologies. Market validation studies help ensure that innovative solutions are aligned with clinical practice and address the challenges faced by both healthcare professionals and patients.

Revitalizing lives, one spine at a time